Volume specific response criteria for brain metastases following salvage stereotactic radiosurgery and associated predictors of response

References

• Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, . New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205–16.
   PubMed Web of Science ®Google Scholar
• Tsimberidou AM, Letourneau K, Wen S, Wheler J, Hong D, Naing A, . Phase I clinical trial outcomes in 93 patients with brain metastases: The MD Anderson Cancer Center Experience. Clin Cancer Res 2011;17:4110–8.
   PubMedGoogle Scholar
• Rodrigues G, Eppinga W, Lagerwaard F, de Haan P, Haasbeek C, Perera F, . A pooled analysis of arc-based image-guided simultaneous integrated boost radiation therapy for oligometastatic brain metastases. Radiother Oncol 2012;102:180–6.
   PubMedGoogle Scholar
• Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, . Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: A randomised controlled trial. Lancet Oncol 2009;10:1037–44.
   PubMed Web of Science ®Google Scholar
• Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207–14.
   PubMed Web of Science ®Google Scholar
• Vogelbaum MA, Angelov L, Lee SY, Li L, Barnett GH, Suh JH. Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin. J Neurosurg 2006;104:907–12.
   PubMed Web of Science ®Google Scholar
• Hopper KD, Kasales CJ, Van Slyke MA, Schwartz TA, TenHave TR, Jozefiak JA. Analysis of interobserver and intraobserver variability in CT tumor measurements. Ajr 1996;167:851–4.
   PubMed Web of Science ®Google Scholar
• Sahgal A, Ma L, Chang E, Shiu A, Larson DA, Laperriere N, . Advances in technology for intracranial stereotactic radiosurgery. Technol Cancer Res Treat 2009;8:271–80.
   PubMed Web of Science ®Google Scholar
• Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, . Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: Final report of RTOG protocol 90–05. Int J Radiat Oncol Biol Phys 2000;47:291–8.
   PubMed Web of Science ®Google Scholar
• Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, . User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability. NeuroImage 2006;31:1116–28.
   PubMed Web of Science ®Google Scholar
• Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, . Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997; 37:745–51.
   PubMed Web of Science ®Google Scholar
• Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: An analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 2008;70:510–4.
   PubMed Web of Science ®Google Scholar
• Prasad SR, Jhaveri KS, Saini S, Hahn PF, Halpern EF, Sumner JE. CT tumor measurement for therapeutic response assessment: Comparison of unidimensional, bidimensional, and volumetric techniques initial observations. Radiology 2002;225:416–9.
   PubMedGoogle Scholar
• Tran LN, Brown MS, Goldin JG, Yan X, Pais RC, McNitt-Gray MF, . Comparison of treatment response classifications between unidimensional, bidimensional, and volumetric measurements of metastatic lung lesions on chest computed tomography. Acad Radio 2004;11:1355–60.
   PubMed Web of Science ®Google Scholar
• Tsao M, Xu W, Sahgal A. A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases. Cancer Epub 2011 Sep 1.
   Google Scholar
• Chang EL, Hassenbusch SJ, 3rd, Shiu AS, Lang FF, Allen PK, Sawaya R, . The role of tumor size in the radiosurgical management of patients with ambiguous brain metastases. Neurosurgery 2003;53:272–80; discussion 80–1.
   PubMedGoogle Scholar
• Selek U, Chang EL, Hassenbusch SJ, 3rd, Shiu AS, Lang FF, Allen P, . Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int J Radiat Oncol Biol Phys 2004;59:1097–106.
   PubMed Web of Science ®Google Scholar
• Seung SK, Sneed PK, McDermott MW, Shu HK, Leong SP, Chang S, . Gamma knife radiosurgery for malignant melanoma brain metastases. Cancer J Sci Am 1998;4:103–9.
   PubMed Web of Science ®Google Scholar
• Yu C, Chen JC, Apuzzo ML, O'Day S, Giannotta SL, Weber JS, . Metastatic melanoma to the brain: Prognostic factors after gamma knife radiosurgery. Int J Radiat Oncol Biol Phys 2002;52:1277–87.
   PubMed Web of Science ®Google Scholar
• Hoffman R, Sneed PK, McDermott MW, Chang S, Lamborn KR, Park E, . Radiosurgery for brain metastases from primary lung carcinoma. Cancer J (Sudbury, Mass.) 2001;7:121–31.
   PubMedGoogle Scholar
• Chao ST, Barnett GH, Vogelbaum MA, Angelov L, Weil RJ, Neyman G, . Salvage stereotactic radiosurgery effectively treats recurrences from whole-brain radiation therapy. Cancer 2008;113:2198–204.
   PubMed Web of Science ®Google Scholar
• Caballero JA, Sneed PK, Lamborn KR, Ma L, Denduluri S, Nakamura JL, . Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy. Int J Radiat Oncol Biol Phys Epub 2011 Nov 11.
   Google Scholar
• Maranzano E, Trippa F, Casale M, Costantini S, Anselmo P, Carletti S, . Reirradiation of brain metastases with radiosurgery. Radiother Oncol Epub 2011 Aug 29.
   Google Scholar
• Sanghera P, Perry J, Sahgal A, Symons S, Aviv R, Morrison M, . Pseudoprogression following chemoradiotherapy for glioblastoma multiforme. Can J Neurol Sci 2010;37:36–42.
   PubMedGoogle Scholar